| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9341611 | Experimental Eye Research | 2005 | 8 Pages |
Abstract
Conclusions. Pioglitazone is effective in decreasing the density of angiogenesis in a VEGF-induced neovascular rat cornea model. There is possibility of even greater effect with higher doses of the drug. Pioglitazone is a promising drug for the treatment of ocular neovascularization.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Melvin A. Sarayba, Li Li, Tulaya Tungsiripat, Norman H. Liu, Paula M. Sweet, Anup J. Patel, Kathryn E. Osann, Amar Chittiboyina, Stephen C. Benson, Harrihar A. Pershadsingh, Roy S. Chuck,